Abstract
Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are pulmonary manifestations of a systemic inflammation that causes thousands of deaths every year around the world. However, there are still no specific treatment for this disease. Thus, based on a systematic review, this study aimed to investigate the anti-inflammatory effects of quercetin in a murine lipopolysaccharide-induced acute lung injury model. The investigation was conducted in the PubMed, Science Direct, Web of Science, and Scopus databases via Periódicos Capes. Initially, 49 articles were found that went through screening and five studies were selected. The results showed that quercetin, when administered as a possible treatment for acute lung injury in mice, reduced markers of inflammation, such as MDA and NO levels, MPO activity, the accumulation of neutrophils in the lung, number of leukocytes in bronchoalveolar lavage (BAL), release of inflammatory cytokines TNF-α, IL-1β and IL-6 in BAL, pulmonary edema and infiltration in lung tissues.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
